Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Spruce Biosciences, Inc. (SPRB) had Debt to Capital Ratio of 0.05 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-16.23M |
|
-- |
|
-- |
|
$16.51M |
|
$-16.51M |
|
$0.28M |
|
$-16.23M |
|
$-16.23M |
|
$-16.23M |
|
$-16.23M |
|
$-16.23M |
|
$-16.23M |
|
$-16.51M |
|
$-15.88M |
|
2.43M |
|
2.43M |
|
$-6.68 |
|
$-6.68 |
|
| Balance Sheet Financials | |
$101.15M |
|
-- |
|
$1.70M |
|
$102.85M |
|
$10.96M |
|
$4.59M |
|
$8.16M |
|
$19.12M |
|
$83.73M |
|
$83.73M |
|
$83.73M |
|
2.75M |
|
| Cash Flow Statement Financials | |
$-30.85M |
|
$-0.14M |
|
$78.39M |
|
$48.94M |
|
$96.33M |
|
$47.39M |
|
$1.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.23 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.05 |
0.08 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-31.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.38% |
|
-19.38% |
|
-15.78% |
|
-18.38% |
|
$30.41 |
|
$-12.75 |
|
$-12.69 |
|